ZEAL:CPH
Zealand Pharma A/S
DKKÂ 221.80
arrow_downward
-1.99%(-4.50) 1D
Oct 19, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
DKKÂ 228.00
High
DKKÂ 229.00
Low
DKKÂ 220.60
Mkt. cap
16.21B
Avg. vol.
396.82K
Volume
280.90K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 220.60
Shares outstanding
71.61M
No. of employees
578
Open
DKKÂ 228.00
High
DKKÂ 229.00
Low
DKKÂ 220.60
Mkt. cap
16.21B
Avg. vol.
396.82K
Volume
280.90K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 220.60
Shares outstanding
71.61M
No. of employees
578
News stories
From web sources and news partners
Investing.com
·
20 hours ago
Zealand Pharma reports positive phase 1 results for ZP9830
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com